-
February 21: The Week in Cancer NewsA study shows that young cancer survivors have a higher death rate than their siblings in the decades following diagnosis, and a cancer survivor has a baby using immature eggs harvested prior to treatment and matured in the lab.
by Kate Yandell
-
February 14: The Week in Cancer NewsA survey finds that outpatient palliative care clinics have become nearly ubiquitous in National Cancer Institute-designated cancer centers, and a group of oncology professionals calls for a cancer patient's bill of rights.
by Kate Yandell
-
February 7: The Week in Cancer NewsA massive sequencing project reveals that mutations that drive cancer often occur years before the disease is diagnosed, and researchers report preliminary results from a trial for a new form of immunotherapy.
by Kate Yandell
-
January 31: The Week in Cancer NewsA randomized trial shows that lung cancer screening reduces lung cancer deaths, and a study indicates that a single dose of psilocybin may have a lasting impact on cancer patients' anxiety and depression.
by Kate Yandell
-
January 24: The Week in Cancer NewsA study shows that the rate of death following bone marrow transplant has decreased, and the U.S. Food and Drug Administration approves a new treatment for patients with a rare form of sarcoma.
by Kate Yandell
-
January 17: The Week in Cancer NewsA study shows that eating more vegetables does not reduce risk of progression for patients with early-stage prostate cancer, and a new website provides information on cancer survival rates.
by Kate Yandell
-
January 10: The Week in Cancer NewsThe rate of cancer deaths in the U.S. has continued to decline, and the U.S. Food and Drug Administration approves a new treatment for a rare cancer type.
by Kate Yandell
-
January 3: The Week in Cancer NewsWhen reading mammograms, an artificial intelligence system yields fewer false-positive and false-negative results than radiologists, and the U.S. Food and Drug Administration approves a targeted therapy for pancreatic cancer.
by Kate Yandell
-
Progress, But Still Room for ImprovementThe winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients.
by Kevin McLaughlin
-
2019: This Year in Cancer NewsThe Cancer Today editorial staff selects some of the most impactful and informative reporting and essays of 2019.
by Cancer Today Staff
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
